Advertisement

FDA cites Hospira for drug manufacturing violations

By Bob Herman  |  October 01, 2014

Drugmaker Hospira said Wednesday that it received a warning letter from the Food and Drug Administration regarding poor manufacturing quality at one of its facilities in Australia.

Premier's TheraDoc deal boosts its clinical surveillance business

Premier's TheraDoc deal boosts its clinical surveillance business

By Bob Herman  |  August 05, 2014

Healthcare supply, analytics and consulting company Premier agreed Tuesday to acquire TheraDoc, a clinical surveillance software company, for $117 million, augmenting Premier's already sizable footprint in the clinical-safety solutions market.

AHA wants FDA to address IV fluids shortage

AHA wants FDA to address IV fluids shortage

By Virgil Dickson  |  March 21, 2014

The American Hospital Association is pushing the Food and Drug Administration to be more aggressive in getting manufacturers of saline and other IV fluids to increase production to alleviate shortages.

FDA efforts take aim at drug shortages

FDA efforts take aim at drug shortages

By Virgil Dickson  |  October 31, 2013

The FDA is releasing a strategic plan to address the underlying causes of drug shortages, and will launch a new mobile app to alert relevant stakeholders when shortages occur.

ActiveCare names Olson CTO

ActiveCare names Olson CTO

By Rachel Landen  |  June 20, 2013

ActiveCare, which provides remote health monitoring for diabetes and chronic disease management, has named Jonathan Olson its chief technology officer.

Hungry for a solution

Hungry for a solution

By Jaimy Lee  |  June 08, 2013

Tim Weaver, an 18-year-old college student who lives in Naperville, Ill., is one of the estimated 30,000 people in the U.S. who rely on intravenous nutrition products to keep them alive.

FDA flags new concerns on Hospira's plant

By Reuters via Yahoo  |  March 05, 2013

Hospira said U.S. health regulators raised fresh concerns about the injectable-drugs maker's troubled Rocky Mount, N.C., manufacturing plant, one of its largest production facilities.

Hospira wins skirmish with SEC

By Kristen Schorsch, Crain's Chicago Business  |  January 15, 2013

Hospira successfully fought off a government request for more details about its prolonged efforts to fix safety problems, a win that highlights the scrutiny of CEO F. Michael Ball's efforts to boost production at the giant medical products maker.

Hospira buys manufacturing, R&D facilities in India

By Jaimy Lee  |  August 30, 2012

Hospira, a Lake Forest, Ill.-based generic drug manufacturer, said it has acquired an active pharmaceutical ingredient, or API, manufacturing facility from an Indian drug company for $200 million.

Infection-control software market poised for growth: KLAS

By Joseph Conn  |  August 28, 2012

The market for infection-control system software is small and is dominated by applications developed specifically for this narrow market niche, but it won't stay that way much longer, according to a report from KLAS Enterprises.

Advertisement